(410 ILCS 405/4)
(from Ch. 111 1/2, par. 6954)
Development of standards for a service network and
designation of regional centers and primary providers. By January 1, 1987, the
Department, in consultation with the Advisory Committee, shall develop
standards for the conduct of research and for the identification,
evaluation, diagnosis, referral and treatment of individuals with Alzheimer's
disease and related disorders and their families through the ADA network of
designated regional centers and other providers of service
under this Act. Such standards shall include all of the following:
(a) A description of the specific populations and
geographic areas to be served through ADA networks that may be established under this Act.
(b) Standards, criteria and procedures for
designation of Regional ADA Centers, which ensure the provision of quality care to a broad segment of the population through on-site facilities and services and through a network of primary Alzheimer's providers and other providers of service that may be available within the service area defined by the Department. At least 2 Regional ADA Centers shall be conveniently located to serve the Chicago metropolitan area and at least one Regional ADA Center shall be conveniently located to serve the balance of the State. The Regional ADA Centers shall provide at least the following:
(1) comprehensive diagnosis and treatment
facilities and services which have (i) professional medical staff specially-trained in geriatric medicine, neurology, psychiatry and pharmacology, and the detection, diagnosis and treatment of Alzheimer's disease and related disorders, (ii) sufficient support staff who are trained as caregivers to individuals with Alzheimer's disease and related disorders, (iii) appropriate and adequate equipment necessary for diagnosis and treatment, and (iv) such other support services, staff and equipment as may be required;
(2) consultation and referral services for
individuals with AD and their families or demonstrated instances of referral to consultation and referral services provided by organizations and agencies specializing in Alzheimer's disease and related disorders for those affected to ensure informed consent to treatment and to assist them in obtaining necessary assistance and support services through primary Alzheimer's providers and various private and public agencies that may otherwise be available to provide services under this Act;
(3) research programs and facilities to assist
faculty and students in discovering the cause of and the diagnosis, cure and treatment for Alzheimer's disease and related disorders;
(4) training, consultation and continuing
education for caregivers or demonstrated instances of referral to training, consultation, and continuing education provided by organizations and agencies specializing in Alzheimer's disease and related disorders for those affected, including families of those who are affected by Alzheimer's disease and related disorders;
(5) centralized data collection, processing and
storage that will serve as a clearinghouse of information to assist individuals with AD, families and ADA Resources, and to facilitate research; and
(6) programs of scientific and medical research
in relation to Alzheimer's disease and related disorders that are designed and conducted in a manner that may enable such center to qualify for Federal financial participation in the cost of such programs.
(c) Procedures for recording and reporting research
and treatment results by primary Alzheimer's providers and other affiliated providers of service that are within the ADA network to the Regional ADA Center and to the Department.
(d) Policies, procedures and minimum standards and
criteria to be included in affiliation agreements between primary Alzheimer's providers and the Regional ADA Center in the conduct of any research and in the diagnosis, referral and treatment of individuals with Alzheimer's disease and related disorders and their families.
(e) Policies, procedures, standards and criteria,
including medical and financial eligibility factors, governing admission to and utilization of the programs, facilities and services available through the ADA network by persons who may be or who have been diagnosed as having Alzheimer's disease or a related disorder, including forms and procedures for obtaining necessary patient consents to participation in research, and in the reporting and processing of appropriate information in a patient's medical records in relation to consultations, referrals and treatments by the various providers of service within the ADA network.
(Source: P.A. 97-768, eff. 1-1-13.)